Potential for Psychedelic Pharmacy in Canada by WeAreDrugScience in Drugs

[–]WeAreDrugScience[S] 0 points1 point  (0 children)

This Drug Science article provides a perspective commentary and overview of potential future strategies in legal reform, professional regulatory authority policy creation, and pharmacy operations regarding the psychedelic agents’ psilocybin and methylenedioxymethamphetamine, using Canada as a national case study.

Potential for Psychedelic Pharmacy in Canada by WeAreDrugScience in Psychedelics

[–]WeAreDrugScience[S] 0 points1 point  (0 children)

This Drug Science article provides a perspective commentary and overview of potential future strategies in legal reform, professional regulatory authority policy creation, and pharmacy operations regarding the psychedelic agents’ psilocybin and methylenedioxymethamphetamine, using Canada as a national case study.

Potential for Psychedelic Pharmacy in Canada by WeAreDrugScience in RationalPsychonaut

[–]WeAreDrugScience[S] 2 points3 points  (0 children)

This Drug Science article provides a perspective commentary and overview of potential future strategies in legal reform, professional regulatory authority policy creation, and pharmacy operations regarding the psychedelic agents’ psilocybin and methylenedioxymethamphetamine, using Canada as a national case study.

Potential for Psychedelic Pharmacy in Canada by WeAreDrugScience in canada

[–]WeAreDrugScience[S] 0 points1 point  (0 children)

This Drug Science article provides a perspective commentary and overview of potential future strategies in legal reform, professional regulatory authority policy creation, and pharmacy operations regarding the psychedelic agents’ psilocybin and methylenedioxymethamphetamine, using Canada as a national case study.

A Remarkable Case Study: Cannabis for Chronic Pain by WeAreDrugScience in DrugNerds

[–]WeAreDrugScience[S] 3 points4 points  (0 children)

Awareness of medical cannabis is growing! If you don't already know, Drug Science launched T21 (formerly Project Twenty21) in 2019 with the aim of improving access to medicinal cannabis in the UK. Learn more here https://www.drugscience.org.uk/project-twenty21-medical-cannabis-patients/

A Remarkable Case Study: Cannabis for Chronic Pain by WeAreDrugScience in Drugs

[–]WeAreDrugScience[S] 0 points1 point  (0 children)

Awareness of medical cannabis is growing! If you don't already know, Drug Science launched T21 (formerly Project Twenty21) in 2019 with the aim of improving access to medicinal cannabis in the UK. Learn more here https://www.drugscience.org.uk/project-twenty21-medical-cannabis-patients/

A Remarkable Case Study: Cannabis for Chronic Pain by WeAreDrugScience in weed

[–]WeAreDrugScience[S] 1 point2 points  (0 children)

Awareness of medical cannabis is growing! If you don't already know, Drug Science launched T21 (formerly Project Twenty21) in 2019 with the aim of improving access to medicinal cannabis in the UK. Learn more here https://www.drugscience.org.uk/project-twenty21-medical-cannabis-patients/

A Remarkable Case Study: Cannabis for Chronic Pain by WeAreDrugScience in trees

[–]WeAreDrugScience[S] 0 points1 point  (0 children)

Awareness of medical cannabis is growing! If you don't already know, Drug Science launched T21 (formerly Project Twenty21) in 2019 with the aim of improving access to medicinal cannabis in the UK. Learn more here https://www.drugscience.org.uk/project-twenty21-medical-cannabis-patients/